ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (1541) Revenue

3 Followers

Statistics Market Cap Revenue

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Revenue

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H had a revenue of 114.33M in the quarter ending Dec 31, 2025, with 159.75%. This bring the company's revenue in the last twelve months to 158.34M, Decreased 28.91%. In the fiscal year ending Dec 31, 2025, ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H had annual revenue of 150.30M with 102.70% growth.

Revenue (ttm)

158.34M

Revenue Growth

109.02%

P/S Ratio

24.73

Revenue/Employee

HK$963,466

Employees

156

Market Cap

HK$3.72B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	150.30M	76.15M	+102.70%
Dec 31, 2024	74.15M	73.76M	+19,109.59%
Dec 31, 2023	386.00K	-5.30M	-93.22%
Dec 31, 2022	5.69M	-8.12M	-58.79%
Dec 31, 2021	13.81M	―	―